Characteristic | Case fatality rate (deaths/no at risk)* | Univariate analysis OR (95%CI) | p | Multivariate analysis, adjusted OR (95%CI), P †|
---|---|---|---|---|
Overall | 15.3% (51/333) | Â | Â | Â |
Age (no of years)‡ | NA | 0.98 (0.97–1.00) | 0.071 | Removed (p = 0.433) |
Sex: | Â | Â | 0.682 | Removed (p = 0.257) |
   Female | 14.5% (24/165) | 1 |  |  |
   Male | 16.2% (27/167) | 1.13 (0.62–2.06) |  |  |
Malaria parasitemia | Â | Â | 0.859 | Â |
   Negative | 15.6% (40/257) | 1 |  |  |
   Positive | 14.3% (4/28) | 0.90 (0.30–2.75) |  |  |
Malaria parasitemia (graded 1–5)‡ | NA | 1.02 (0.75–1.40) | 0.889 |  |
High parasitemia | Â | Â | 0.261 | Â |
   <5% of erythrocytes | 14.8% (40/270) | 1 |  |  |
   ≥ 5% of erythrocytes | 27.3% (3/11) | 2.16 (0.55–8.52) |  |  |
Initial diagnosis | Â | Â | 0.936 | Â |
   Other than malaria | 15.3% (43/282) | 1 |  |  |
   Presumptive malaria | 15.7% (8/51) | 1.03 (0.45 – 2.35) |  |  |
Retrospective diagnosis | Â | Â | 0.166 | Removed (p = 0.401) |
   Other than malaria | 20.9% (39/187) | 1 |  |  |
   Verified malaria | 8.7% (2/23) | 0.36 (0.08 – 1.62) |  |  |
HIV test result | Â | Â | 0.103 | Removed (p = 0.290) |
   Negative | 10.7% (9/84) | 1 |  |  |
   Positive | 18.6% (35/188) | 1.91 (0.87–4.19) |  |  |
CDC HIV stage‡§ | NA | 1.36 (1.04–1.78) | 0.026 | 1.87 (1.01–3.47) p = 0.048 |
Anti retroviral therapy | Â | Â | 0.953 | Â |
   Not on ART | 15.4% (45/293) | 1 |  |  |
   On ART | 15.0% (6/40) | 0.97 (0.39–2.45) |  |  |
Hypotension |  |  | 0.057 | 4.02 (1.01–15.89) p = 0.048 |
   No hypotension reported | 14.5% (46/318) | 1 |  |  |
   Blood pressure <90 mmHg | 33.3% (5/15) | 2.96 (0.97–9.04) |  |  |
Neck stiffness | Â | Â | 0.323 | Â |
   No neck stiffness reported | 15.8% (50/317) | 1 |  |  |
   Stiff neck | 6.3% (1/16) | 0.36 (0.05–2.76) |  |  |
Cough | Â | Â | 0.757 | Â |
   No cough reported | 14.9% (36/241) | 1 |  |  |
   Coughing | 16.3% (15/92) | 1.11 (0.58–2.14) |  |  |
Diarrhoea | Â | Â | 0.862 | Â |
   No diarrhoea reported | 15.5% (43/278) | 1 |  |  |
   Diarrhoea present | 14.5% (8/55) | 0.93 (0.41–2.11) |  |  |
Serum creatinine | Â | Â | 0.907 | Â |
   < 175 μmol/L or not tested | 15.2% (44/289) | 1 |  |  |
   ≥ 175 μmol/L | 15.9% (7/44) | 1.05 (0.44–2.51) |  |  |
Platelet counts |  |  | 0.008 | 2.23 (0.94–5.33) p = 0.070 |
   ≥ 100 × 109/L or not tested | 13.1% (37/283) | 1 |  |  |
   <100 × 109/L | 28.0% (14/50) | 2.59 (1.27–4.5.25) |  |  |
Blood-glucose |  |  | <0.001 | 13.57 (2.69–68.45) p = 0.002 |
   ≥ 2.2 mmol/L or not tested | 14.2% (46/324) | 1 |  |  |
   <2.2 mmol/L | 55.6% (5/9) | 7.55 (1.96–29.18) |  |  |